Survival Outcomes and Survival Predictors in Recurrent and Metastatic Head and Neck Squamous Cell Cancer (R/M-HNSCC) Patients Treated with Chemotherapy (CT) Plus Cetuximab As First-Line Therapy in a Real-World Study